Cured Raises $10M Series A; Launches Next Generation Healthcare Digital Marketing & CRM Solutions

BOULDER, CO, September 15, 2021 — Cured, a healthcare digital marketing and customer relationship management (CRM) platform, today announced it has closed an oversubscribed $10 million Series A funding round. The round was led by DNA Capital and included participation from new investors CU Healthcare Innovation Fund and UCHealth. Existing investors High Alpha, Waterline Ventures, Matchstick Ventures, and Headwater Ventures also participated. As a part of the round, Partha Mishra, Partner at DNA Capital and experienced healthcare executive, will join Cured’s Board of Directors.

“Today’s healthcare organizations have substantial opportunity to differentiate themselves by providing consumers with curated experiences that individuals and their families have become accustomed to with their favorite retail, consumer goods, or even financial service brands,” said Andrew Sawyer, co-founder and Chief Executive Officer of Cured. “The reality is, the existing digital marketing & CRM platforms are not well suited to meet the unique needs of healthcare. The industry has particular security, compliance, and data needs. Moreover, patient and member experiences in healthcare are highly contextual. The ability to educate and provide digital interactions specific to an individual’s healthcare needs throughout the patient or member journey can markedly improve engagement and loyalty.”

Since launching in May 2018, Cured has partnered with leading health systems, healthcare services, and digital health organizations to transform their growth and experience strategies through technology. To date, Cured’s customers have sent over 35 million interactions through the company’s solutions. Such interactions focus on driving consumers to preventative services, making individuals aware of convenient healthcare options applicable to their needs, and providing guidance along specific care journeys to improve adherence and engagement.

“Healthcare organizations have access to more customer data than arguably any other industry. However, their ability to mobilize and use this data to create meaningful experiences for their customers lags behind most of their industry peers,” stated Ashmer Aslam, co-founder and Chief Technology Officer of Cured. “Our platform aims to solve that problem by making this data actionable. We achieve this by applying analytics and machine learning that is contextually aware of the target audience; and, in turn, we can apply predictions to create meaningful audience segmentation to maximize personalization, precision, and action.”

In conjunction with the funding, the company launched Curations, a catalog of over 70+ prebuilt patient and customer journey campaigns to aid healthcare organizations in attracting, engaging, and retaining healthcare consumers. Curations include audience and segmentation configuration, content and creative templates, and automation available out of the box to support the strategies that matter most to leading healthcare organizations.

“We at DNA Capital are delighted to partner with Cured as they are poised to scale their healthcare native, enterprise-grade digital marketing and CRM solutions to transform how healthcare organizations build lasting relationships with their customers,” said Mishra. “We are equally excited to back the top-notch founding team — a rare blend of talent with a deep understanding of health systems strategy, experience in architecting scalable SaaS solutions, and proven ability to cultivate trusted relationships with enterprise customers.”

Cured will use the funding to accelerate the advancement of its Digital Marketing and Insights platform. Further, the funding will support the continued growth of its team of healthcare and customer experience experts across its locations in Boulder, Chicago, and Indianapolis. The team is actively hiring talent in software engineering, business development, and customer delivery. For more information on hiring and openings, visit: cured.health/about#join-us

About Cured

Cured is a healthcare digital marketing and CRM platform that enables healthcare organizations to create unparalleled relationships with their consumers and key B2B partners. With its technology, Cured partners with top healthcare organizations to deliver on a collective mission to bring care full circle. Cured has offices in Boulder, Chicago, and Indianapolis and is backed by leading investors like DNA Capital, High Alpha, Matchstick Ventures, and Waterline Ventures. For more information, please visit cured.health and follow us on LinkedIn.

About DNA Capital

DNA Capital manages $3.5Bn in AuM and invests globally in multiple stages across healthcare, from health management to production and distribution to healthcare innovation and technology. With headquarters in São Paulo, Brazil and offices in San Francisco, DNA Capital has a distinguished and decades long record of connecting, accelerating and optimizing companies and technologies in the healthcare space. Current Investments include Alto Pharmacy, Galileo, Clover Health, DASA, Viveo, Beep! and Memed. For more information, please visit https://dnacapital.com/en.

Author Information

As a detail-oriented researcher, Sherril is expert at discovering, gathering and compiling industry and market data to create clear, actionable market and competitive intelligence. With deep experience in market analysis and segmentation she is a consummate collaborator with strong communication skills adept at supporting and forming relationships with cross-functional teams in all levels of organizations.

Sherril holds a Master of Business Administration in Marketing from University of Colorado, Boulder and a Bachelor of Arts in Psychology from Rutgers University.

Latest Insights:
FPT IS Bets on Silicon-Software Convergence at VKAISS 2026
November 14, 2026
Article
Article

FPT IS Bets on Silicon-Software Convergence at VKAISS 2026

FPT IS signals strategic pivot toward silicon-software convergence, signing four MOUs with Korean semiconductor partners at VKAISS 2026 to capitalize on Vietnam's semiconductor buildout and Asia-Pacific AI growth....
Wavestone's EU AI Office Role Turns Regulation Into Revenue
November 14, 2026
Article
Article

Wavestone’s EU AI Office Role Turns Regulation Into Revenue

Wavestone joined a Capgemini-led consortium selected by the EU to assess cyber risks of advanced AI models, validating its dual expertise in cybersecurity and AI while capitalizing on growing compliance demand....
Credence's DAAS Recompete Win: Defense SLE at Scale
November 14, 2026
Article
Article

Credence’s DAAS Recompete Win: Defense SLE at Scale

Credence secured a recompete award to continue developing the Defense Logistics Agency's DAAS API Gateway on MuleSoft Anypoint, processing 14+ billion transactions annually at Impact Level 5 security....
Commvault Bets That Recovery Is What Lets Enterprises Say Yes to AI
November 13, 2026
Article
Article

Commvault Bets That Recovery Is What Lets Enterprises Say Yes to AI

Fernando Montenegro, Vice President & Practice Lead, Cybersecurity & Resilience at Futurum, Commvault's Recovery Studio positions orchestrated, full-stack recovery as the foundation for enterprise confidence in AI deployment....
Latest Research:
Remediation Is Becoming a Software Delivery Capacity Problem
November 4, 2026

Remediation Is Becoming a Software Delivery Capacity Problem

In our latest thought leadership brief, Remediation Is Becoming a Software Delivery Capacity Problem, completed in partnership with Google Cloud, Futurum Research examines why the queue between a validated finding...
November 2, 2026

Specialized AI Clouds Belong on the Shortlist for Multi-Year AI Commitments

In our latest thought leadership brief, Specialized AI Clouds Belong on the Shortlist for Multi-Year AI Commitments, completed in partnership with CoreWeave, Futurum Research examines why enterprises signing multi-year AI...
Documents Are the Overlooked Layer of Enterprise AI Strategy
October 28, 2026

Documents Are the Overlooked Layer of Enterprise AI Strategy

In our latest thought leadership brief, Documents Are the Overlooked Layer of Enterprise AI Strategy, completed in partnership with Adobe, Futurum Research examines why the documents that hold a company's...

Book a Demo

Welcome

The vision behind everything in Futurum’s Custom Research practice is this: research should show you what is happening, what comes next, and what to do about it. It should be personal to each audience, easy for people to grasp, and structured so LLMs can reason over it accurately. And it should be fast and turnkey; you want answers now, not another project to carry for quarters.

Whether you are defining business, channel, or go-to-market strategy; evaluating vendors or justifying ROI; or commissioning research to fill an emerging market need, we have your back, with a program that answers your questions with the objectivity and credibility to drive real decisions.

To do it, we bring unmatched data to bear: Futurum research, surveys, and market projections; validated market feeds; ETR’s 15 years of insight from 10,000 technology decision-makers; G2’s buyer and user data; and what our analysts hear every day. Add leading primary collection, from AI-moderated voice interviews to surveys and analyst-led interviews, all turnkey, and every project comes out credible, nuanced, and actionable.

And we don’t just drop the results in your lap. For internal work, we provide analyst-led sessions, interactive dashboards, and a range of formats. For market-facing work, Futurum delivers turnkey activation and amplification that actually gets seen, by people and by LLMs, through our media and share of voice. This is research that moves decisions and markets.

We will meet you wherever you are, from a fast-turn brief to a multi-year program, and shape the work to your goals, timeline, and budget. The right program for your moment.

If any of this is useful, I would love to talk.

Benjamin Brown, VP Custom Research, Futurum Research

Benjamin Brown

VP, Custom Research · The Futurum Group

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.